Online Education | Hepatitis C Online | State of the Art Therapy for HCV
This module includes a review of all FDA-approved agents used to treat hepatitis C, including newer FDA-approved direct acting agents. The content will address the virologic responses to therapy, recommended therapy for treatment-naïve and treatment experienced patients, and monitoring and management of treatment-related adverse effects.
Primary care physicians, advanced registered nurse practitioners, physician assistants, hospitalizes, infectious disease specialists, gastroenterologists and hepatologists
Objectives for Learning Outcomes
After completing this course, you will be better able to:
- Discuss the rapidly changing treatment landscape for hepatic C.
- List 3 medications not yet FDA-approved that show promise for treating genotype 1 HCV.
Robert G. Gish, MD
Senior Medical Director, St Josephs Hospital and Medical Center Liver Program, Phoenix, Arizona
Clinical Professor of Medicine, University of Nevada, Las Vegas
- 0.75 Contact hours